Working… Menu

Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03341962
Recruitment Status : Recruiting
First Posted : November 14, 2017
Last Update Posted : July 2, 2021
Information provided by (Responsible Party):
Immunic AG

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 10, 2022
Estimated Study Completion Date : June 30, 2029